Page last updated: 2024-10-30

mebendazole and Prostatic Neoplasms, Castration-Resistant

mebendazole has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research Excerpts

ExcerptRelevanceReference
"Flubendazole is a well-known anti-malarial drug that is recently reported to be a potential anti-tumor agent in various types of human cancer cells."1.62Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. ( Cen, S; Chen, W; Li, C; Luo, J; Mao, X; Shu, F; Tan, X; Wu, K; Yang, T; Yang, Y; Zhou, X; Zou, L, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhou, X1
Zou, L1
Chen, W1
Yang, T1
Luo, J1
Wu, K1
Shu, F1
Tan, X1
Yang, Y1
Cen, S1
Li, C1
Mao, X1

Other Studies

1 other study available for mebendazole and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.
    Pharmacological research, 2021, Volume: 164

    Topics: Amino Acid Transport System y+; Animals; Anthelmintics; Antineoplastic Agents; Antineoplastic Combin

2021